RAD6 promotes DNA repair and stem cell signaling in ovarian cancer and is a promising therapeutic target to prevent and treat acquired chemoresistance. [electronic resource]
Producer: 20171207Description: 6680-6690 p. digitalISSN:- 1476-5594
- Antineoplastic Agents -- pharmacology
- Carboplatin -- pharmacology
- Carcinoma, Ovarian Epithelial
- Cell Line, Tumor
- DNA Repair
- DNA Replication
- Disease-Free Survival
- Drug Resistance, Neoplasm
- Female
- Humans
- Neoplasms, Glandular and Epithelial -- drug therapy
- Neoplastic Stem Cells -- enzymology
- Ovarian Neoplasms -- drug therapy
- Prognosis
- Signal Transduction
- Ubiquitin-Conjugating Enzymes -- physiology
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.